Back
ProShares Ultra Nasdaq Biotechnology Stock Price Chart
2025 Gold Forecast: A Perfect Storm for Demand
Discover our Gold Price Outlook for 2025--FREE--here
Sell
31
BIB
ProShares Ultra Nasdaq Biotechnology
Last Price:
$51.98
Seasonality Move:
5.96%
7 Day Trial
ALL ACCESS PASS
$
7
Elon Musk Predicts MAJOR Crisis in Trump's First Year
See Why Investors are Pouring Mountains of Cash into Certain Companies Trump Wants to Solve the Problem.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BIB is experiencing buying pressure, which is a positive indicator for future bullish movement.
ProShares Ultra Nasdaq Biotechnology Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 53.31 | Sell |
| 20-day SMA: | 56.55 | Sell |
| 50-day SMA: | 59.53 | Sell |
| 200-day SMA: | 59.75 | Sell |
| 8-day EMA: | 53.29 | Sell |
| 20-day EMA: | 55.59 | Sell |
| 50-day EMA: | 58.42 | Sell |
| 200-day EMA: | 59.46 | Sell |
ProShares Ultra Nasdaq Biotechnology Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.11 | Sell |
| Relative Strength Index (14 RSI): | 35.47 | Sell |
| Chaikin Money Flow: | 8632 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (53.34 - 59) | Sell |
| Bollinger Bands (100): | (57.63 - 66.09) | Sell |
ProShares Ultra Nasdaq Biotechnology Technical Analysis
| Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for ProShares Ultra Nasdaq Biotechnology Stock
Is ProShares Ultra Nasdaq Biotechnology Stock a Buy?
-
ProShares Ultra Nasdaq Biotechnology share price is 52.19 while BIB 8-day simple moving average is 53.31, which is a Sell signal.
-
The stock price of BIB is 52.19 while ProShares Ultra Nasdaq Biotechnology 20-day SMA is 56.55, which makes it a Sell.
-
ProShares Ultra Nasdaq Biotechnology 50-day simple moving average is 59.53 while BIB share price is 52.19, making it a Sell technically.
-
BIB stock price is 52.19 and ProShares Ultra Nasdaq Biotechnology 200-day simple moving average is 59.75, creating a Sell signal.
BIB Technical Analysis vs Fundamental Analysis
Sell
31
ProShares Ultra Nasdaq Biotechnology (BIB)
is a Sell
Is ProShares Ultra Nasdaq Biotechnology a Buy or a Sell?
-
ProShares Ultra Nasdaq Biotechnology stock is rated a SellThe current ProShares Ultra Nasdaq Biotechnology [BIB] share price is $52.19. The Score for BIB is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
ProShares Ultra Nasdaq Biotechnology Stock Info
Market Cap:
0
Price in USD:
52.19
Share Volume:
8.6K
ProShares Ultra Nasdaq Biotechnology 52-Week Range
52-Week High:
69.56
52-Week Low:
47.20
Sell
31
ProShares Ultra Nasdaq Biotechnology (BIB)
is a Sell
ProShares Ultra Nasdaq Biotechnology Share Price Forecast
-
What is the ProShares Ultra Nasdaq Biotechnology stock price today?The ProShares Ultra Nasdaq Biotechnology stock price is 52.19 USD today.
-
Will BIB stock go up or go down?ProShares Ultra Nasdaq Biotechnology> share price is forecast to RISE/FALL based on technical indicators
-
Is ProShares Ultra Nasdaq Biotechnology overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, ProShares Ultra Nasdaq Biotechnology is overvalued.
Is ProShares Ultra Nasdaq Biotechnology Stock a Buy?
-
ProShares Ultra Nasdaq Biotechnology share price is 52.19 while BIB 8-day exponential moving average is 53.29, which is a Sell signal.
-
The stock price of BIB is 52.19 while ProShares Ultra Nasdaq Biotechnology 20-day EMA is 55.59, which makes it a Sell.
-
ProShares Ultra Nasdaq Biotechnology 50-day exponential moving average is 58.42 while BIB share price is 52.19, making it a Sell technically.
-
BIB stock price is 52.19 and ProShares Ultra Nasdaq Biotechnology 200-day simple moving average is 59.46, creating a Sell signal.
Technical Analysis of ProShares Ultra Nasdaq Biotechnology
Should I short ProShares Ultra Nasdaq Biotechnology stock?
-
BIB Moving Average Covergence Divergence (MACD) indicator is -2.11, suggesting ProShares Ultra Nasdaq Biotechnology is a Sell
-
ProShares Ultra Nasdaq Biotechnology Relative Strength Index (RSI) is 35.47, which suggest ProShares Ultra Nasdaq Biotechnology is oversold
-
The Bollinger Bands (25) for ProShares Ultra Nasdaq Biotechnology is (53.34 - 59), which suggest ProShares Ultra Nasdaq Biotechnology is a Sell
-
The Bollinger Bands (100) for ProShares Ultra Nasdaq Biotechnology is (57.63 - 66.09), which suggest ProShares Ultra Nasdaq Biotechnology is a Sell
* ProShares Ultra Nasdaq Biotechnology stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.